Global Locations

Palbociclib D8



Chemical Properties of 'Palbociclib D8'

CAT No. :

CS-O-15447
CAS Registry No. : 1628752-83-9
Category : Isotope Labelled Compounds
Molecular Weight: 455.58
Molecular Formula : C₂₄H₂₁D₈N₇O₂



OTHER INFORMATION of 'Palbociclib D8'
Purity : Not less than 90%
Therapeutic : Anti-Cancer / Oncology
Isotopic Enrichment : Not less than 95%
Purity : Not less than 90%
Therapeutic : Anti-Cancer / Oncology
Isotopic Enrichment : Not less than 95%
IUPAC Name :6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)pyridin-2-yl]amino]pyrido[2,3-d]pyrimidin-7-one
Applicationnotes :"Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
Synonym :Not Available
References :"Finn; R,; et al,: Breast Cancer Res,; 11; 5 (2009)"
Smileys :O=C1C(C(C)=O)=C(C)C2=CN=C(NC3=NC=C(N4C([2H])([2H])C([2H])([2H])NC([2H])([2H])C4([2H])[2H])C=C3)N=C2N1C5CCCC5
Appearance :Pale yellow to yellow solid
Other Synonyms :Palbociclib-d8
Exact Mass :455.28848716
InChI :InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)/i9D2,10D2,11D2,12D2
InchIKey :AHJRHEGDXFFMBM-PMCMNDOISA-N
Canonical SMILES :CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C
Isomeric SMILES :[2H]C1(C(N(C(C(N1)([2H])[2H])([2H])[2H])C2=CN=C(C=C2)NC3=NC=C4C(=C(C(=O)N(C4=N3)C5CCCC5)C(=O)C)C)([2H])[2H])[2H]
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back


More information about Palbociclib


Palbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved as a cancer therapy.





This page contains information about Palbociclib D8 , Palbociclib D8 cas, Palbociclib D8 synthesis, Palbociclib D8 suppliers

What is Palbociclib D8 ?
Palbociclib D8 falls under Isotope Labelled Compounds of Palbociclib."Palbociclib-d8 is labelled Palbociclib, an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6."
What is the CAS Number of Palbociclib D8?
The CAS Number of Palbociclib D8 is 1628752-83-9
Who are the suppliers of Palbociclib D8?
CLEARSYNTH is a worldwide supplier of Palbociclib D8

Related compounds of Palbociclib D8

Looking for a discounted price or need more info for 'Palbociclib D8 (CS-O-15447)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for 'Palbociclib D8 (CS-O-15447)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.